Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors
T. Slagsvold et al., Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors, MOL ENDOCR, 14(10), 2000, pp. 1603-1617
A short C-terminal sequence that forms the core of the activation function-
2 (AF-2) domain is conserved in members of the nuclear receptor superfamily
and is required for their normal biological function. Despite a high degre
e of sequence similarity, there are differences in the context and structur
e of AF-2 in different nuclear receptors, To gain deeper insight into these
differences, we carried out an extensive mutational analysis of the AF-2 c
ore in the androgen receptor (AR) and compared the changes in transcription
al activity with similar mutations that have previously been generated in o
ther nuclear receptors. Mutagenesis of Met894 to Asp resulted in substantia
l decreases in both DNA and ligand binding activities and, consequently, a
significant drop in ligand-dependent transcriptional activation. In contras
t, substitution of Met894 with Ala did not affect DNA or hormone binding, a
nd the transactivation potential was comparable to that of wild-type AR. Mu
tagenesis of Glu897 either with Val or Ala significantly impaired ligand-de
pendent activation that was not due to changes in DNA or ligand binding. Th
ere are both similarities and distinct differences between these findings c
ompared with previous mutagenesis studies of the corresponding residues in
other nuclear receptors. All mutants efficiently interfered with AP-1 activ
ity, indicating that ligand-dependent activation of transcription and inter
ference with AP-1 activity are separable functions in AR. For the Glu897 su
bstitutions, the decrease in ligand-dependent transactivation could partial
ly be reversed by overexpression of GRIP1 (GR-interacting protein 1) or CBP
, putative coactivators for AR. However, there was no correlation between l
igand-dependent in vitro or in vivo association with coactivators and the a
bility of the mutants to support ligand-dependent transactivation. This is
in contrast to similar mutations in other nuclear receptors that lose inter
actions with putative coactivators concomitant with their loss of transcrip
tional activity. However, the Glu897 mutations disrupted the intramolecular
interaction between the N-terminal domain and the ligand-binding domain of
AR that was recently suggested to be required for normal AR function. We c
onclude that residues in the AF-2 core domain of AR make distinctly differe
nt contributions to its transcriptional activities compared with those of o
ther nuclear receptors studied to date.